Developers of the CoviVac vaccine published results of the first two phases of studies on safety and immunogenicity conducted with the participation of volunteers from 18 to 60 years old. experts, interviewees The BBC Russian Service (the media recognized it as a foreign agent) notes the extremely low effectiveness of the vaccine. PhD Tatyana Dudnakova […]